Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808332 | 12580833 | 2 | F | 20160601 | 20160804 | 20160721 | 20160809 | EXP | IT-MINISAL02-366712 | IT-MYLANLABS-2016M1029247 | MYLAN | 0.00 | Y | 0.00000 | 20160809 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125808332 | 12580833 | 1 | PS | LINEZOLID. | LINEZOLID | 1 | Oral | 1200 MG, QD | Y | 78845 | 1200 | MG | TABLET | QD | |||||
| 125808332 | 12580833 | 2 | SS | LINEZOLID. | LINEZOLID | 1 | Y | 78845 | TABLET | ||||||||||
| 125808332 | 12580833 | 3 | SS | LINEZOLID. | LINEZOLID | 1 | Y | 78845 | TABLET | ||||||||||
| 125808332 | 12580833 | 4 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Subcutaneous | 200 MG, QD | Y | 0 | 200 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INFUSION | QD | |||||
| 125808332 | 12580833 | 5 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Y | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INFUSION | ||||||||||
| 125808332 | 12580833 | 6 | SS | TIGECYCLINE. | TIGECYCLINE | 1 | Y | 0 | POWDER AND SOLVENT FOR SOLUTION FOR INFUSION | ||||||||||
| 125808332 | 12580833 | 7 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | UNK UNK, QD | Y | 0 | TABLET | QD | |||||||
| 125808332 | 12580833 | 8 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Y | 0 | TABLET | ||||||||||
| 125808332 | 12580833 | 9 | SS | SULFAMETHOXAZOLE AND TRIMETHOPRIM | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Y | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125808332 | 12580833 | 1 | Meningitis bacterial |
| 125808332 | 12580833 | 2 | Brain abscess |
| 125808332 | 12580833 | 3 | Encephalitis |
| 125808332 | 12580833 | 4 | Meningitis bacterial |
| 125808332 | 12580833 | 5 | Brain abscess |
| 125808332 | 12580833 | 6 | Encephalitis |
| 125808332 | 12580833 | 7 | Meningitis bacterial |
| 125808332 | 12580833 | 8 | Brain abscess |
| 125808332 | 12580833 | 9 | Encephalitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125808332 | 12580833 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125808332 | 12580833 | Hypofibrinogenaemia | |
| 125808332 | 12580833 | Rash | |
| 125808332 | 12580833 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125808332 | 12580833 | 1 | 20160504 | 20160523 | 0 | |
| 125808332 | 12580833 | 4 | 20160504 | 20160523 | 0 | |
| 125808332 | 12580833 | 7 | 20160523 | 20160602 | 0 |